iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma.
Juan Jose Nieto-FontarigoFrancisco Javier González-BarcalaLuis Juan Andrade-BulosMaría Esther San-JoséMaría Jesús CruzLuis Valdés-CuadradoRosa María CrujeirasPilar AriasFrancisco Javier SalgadoPublished in: Allergy (2020)
Our data suggest a set of serum biomarkers, especially IGFALS, capable of differentiating allergic from nonallergic asthma. These proteins reveal different pathophysiological mechanisms and may be useful in the future for diagnosis, prognosis or targeted therapy purposes.